Deutsch English Français

Contact

EP1954717

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1954717

EP1954717 - PEPTIDE INHIBITORS OF ABL KINASES [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 21.06.2013 Database last updated on 31.08.2024
Most recent event Tooltip	21.06.2013	Application deemed to be withdrawn	published on 24.07.2013 [2013/30]
Applicant(s)	For all designated states THE NEW YORK BLOOD CENTER, INC. 310 East 67th Street New York, NY 10021-6295 / US
	[2008/33]
Inventor(s)	01 / KOTULA, Leszek 14 Osprey Ct. Marlboro, NJ 07746 / US
	02 / XIONG, Xiaoling 73-71 194th Street Fresh Meadows, NY 11366 / US
	[2008/33]
Representative(s)	Thomas, Simon Urquhart-Dykes & Lord LLP 3rd Floor 33 Glasshouse Street London W1B 5DG / GB
	[N/P]
Former [2009/11]	Thomas, Simon Urquhart-Dykes & Lord LLP 30 Welbeck Street London W1G 8ER / GB
Former [2008/33]	Green, Mark Charles Urquhart-Dykes & Lord LLP 30 Welbeck Street London W1G 8ER / GB
Application number, filing date	06844600.4	29.11.2006
	[2008/33]
	WO2006US45570
Priority number, date	US20050741208P	01.12.2005 Original published format: US 741208 P
	[2008/33]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2007064647
	Date:	07.06.2007
	Language:	EN
	[2007/23]
	Type:	A2 Application without search report
	No.:	EP1954717
	Date:	13.08.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 07.06.2007 takes the place of the publication of the European patent application.
	[2008/33]
Search report(s)	International search report - published on:	US	27.03.2008
	(Supplementary) European search report - dispatched on:	EP	10.06.2009
Classification	IPC:	C07K14/47, C07K7/08, C12Q1/48, A61K38/00	[2009/28]
	CPC:	C07K14/475 (EP,US); A61P13/08 (EP); A61P35/00 (EP); A61P35/02 (EP); A61P43/00 (EP); C07K14/4702 (EP,US); (+) C12Q1/485 (EP,US); A61K38/00 (EP,US) (-)
	Former IPC [2008/44]	C07K16/00, C12P21/08
	Former IPC [2008/33]	C07K16/00
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/33]
Title	German:	PEPTID-HEMMER VON ABL-KINASE	[2008/33]
	English:	PEPTIDE INHIBITORS OF ABL KINASES	[2008/33]
	French:	INHIBITEURS PEPTIDIQUES DE KINASES ABL	[2008/33]
Entry into regional phase	04.06.2008	National basic fee paid
	04.06.2008	Search fee paid
	04.06.2008	Designation fee(s) paid
	04.06.2008	Examination fee paid
Examination procedure	04.06.2008	Amendment by applicant (claims and/or description)
	04.06.2008	Examination requested [2008/33]
	21.10.2009	Despatch of a communication from the examining division (Time limit: M06)
	22.04.2010	Reply to a communication from the examining division
	04.11.2010	Despatch of a communication from the examining division (Time limit: M06)
	09.05.2011	Reply to a communication from the examining division
	28.10.2011	Despatch of a communication from the examining division (Time limit: M04)
	07.03.2012	Reply to a communication from the examining division
	16.07.2012	Despatch of a communication from the examining division (Time limit: M06)
	29.01.2013	Application deemed to be withdrawn, date of legal effect [2013/30]
	05.03.2013	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/30]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.10.2009
Fees paid	Renewal fee
	04.06.2008	Renewal fee patent year 03
	25.11.2009	Renewal fee patent year 04
	24.11.2010	Renewal fee patent year 05
	23.11.2011	Renewal fee patent year 06
	26.11.2012	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[PX]WO2006086111 (CELL SIGNALING TECHNOLOGY INC [US], et al) [PX] 1,3-9 * figure 2; sequences 2,4 *;
		[XY] - SHI YANGGU ET AL, "Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity", GENES AND DEVELOPMENT, (1995), vol. 9, no. 21, ISSN 0890-9369, pages 2583 - 2597, XP002529065 [X] 1,3-17 * abstract * * page 2593, column 1, line 50 - line 58 * [Y] 2 DOI: http://dx.doi.org/10.1101/gad.9.21.2583
		[Y] - KOTULA L ET AL, "The role of human spectrin SH3 domain binding protein 1 (HSSH3BP1) in prostatic adenocarcinoma", (200409), URL: http://www.dtic.mil/cgi-bin/GetTRDoc?AD=ADA430579&Location=U2&doc=GetTRDoc.pdf, (20090525), XP002529066 [Y] 2 * page 6, paragraph 2 - paragraph L *
		[A] - KOTULA L ET AL, "The role of human spectrin SH3 domain binding protein 1 (HSSH3BP1) in prostatic adenocarcinoma", (200309), URL: http://www.dtic.mil/cgi-bin/GetTRDoc?AD=ADA419543&Location=U2&doc=GetTRDoc.pdf, (20090525), XP002529067 [A] 2 * page 6, paragraph L - page 7, paragraph L *
		[A] - KOTULA L ET AL, "Phosphorylation of Abi-1/Hssh3bp1 by c-Abl tyrosine kinase in vitro and in NIH 3T3 cells", MOLECULAR BIOLOGY OF THE CELL, BETHESDA, MD, US, (20041208), vol. 15, no. SUPPL. S, ISSN 1059-1524, page 413A, XP008106394 [A] 2 * abstract *
		[T] - XIONG X ET AL, "Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1", BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR CELL RESEARCH, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 1783, no. 5, ISSN 0167-4889, (20080501), pages 737 - 747, (20080215), XP022609558 [T] * the whole document * DOI: http://dx.doi.org/10.1016/j.bbamcr.2008.01.028
	International search	[Y]US6255074 (PENDERGAST ANN-MARIE [US], et al);
		[X]US2005003450 (RUSH JOHN [US], et al);
		[Y]US2005065081 (DOREY KAREL [GB], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p